Company Profile
Updated: 30-OCT-09Concateno PLC
International public company
10 Buckingham St., London, WC2N 6DF, United Kingdom
()44 020 7004 2800, 44 020 7004 2801 fax, http://www.concateno.com
Primary SIC: In Vitro & In Vivo Diagnostic Agents, Primary NAICS: In-Vitro Diagnostic Substance Manufacturing
Description: Manufacturing: The development, manufacture and sale of medical diagnostic tests and services, predominantly those used for the detection of alcohol and drugs of abuse.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
FRAMLINGTON AIM VCT 2 PLC - Half-yearly Report.
PR Newswire UK Disclose; 10/29/2009; 6350 words; Framlington AIM VCT 2 PLC Interim report for the six months ended 31 August 2009 Overview of...Company has benefited from the takeover of the diagnostic company, Concateno, at a profit, and awaits the conclusion of the corporate acquisition...
Inverness Medical Innovations Announces Third Quarter 2009 Results.
PR Newswire; 10/27/2009; 5321 words; ...connection with the acquisition of Concateno plc, a $1.9 million compensation...connection with the acquisition of Concateno plc, a $0.3 million loss recorded...established in connection with the Concateno plc acquisition. GAAP results for...
Reportlinker Adds World Markets for Point of Care Diagnostics 2009-13 Report.
PR Newswire; 9/24/2009; 3030 words; ...Alere Medical Inc -- ARKRAY -- Axis-Shield plc -- Bayer Diabetes Care -- Beckman Coulter Inc...Chempaq A/S -- Cholestech Corporation -- Concateno Plc / Cozart Plc -- Crescent Diagnostics Ltd. -- DexCom, Inc...
S&P rates Inverness Medical Innovations' USD 100m notes at B-.
ADP Debt News; 9/23/2009; 547 words; ...health of its employees and covered lives. The transaction follows the recent USD 170 million acquisition of British Concateno plc, a provider of drugs of abuse testing. Both deals expand Inverness' product and service offerings. The B+ corporate...
UBS Investment Bank Strengthens Healthcare Banking Team by Hiring Four Managing Directors.
Business Wire; 9/16/2009; 1517 words; ...Initial Public Offering, the first U.S. biopharmaceutical IPO in the last 22 months; Exclusive Financial Advisor to Concateno Plc on its $240 million sale to Inverness Medical Innovations, Inc.; Joint Bookrunning Manager on Merck & Co...
Recent News Articles
- Inverness Medical Innovations - Concateno plc, Further Announcement Regarding UK Takeover Code Share Dealing Disclosure Requirements.
PR Newswire - June 30, 2009 - Inverness Medical Innovations Proposes to Acquire Concateno plc.
Investment Weekly News - June 20, 2009 - Inverness Medical Innovations Proposes to Acquire Concateno plc.
PR Newswire - June 05, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning